Bart Bierling is a Medical product developer and founder at GOAL 3 in the Netherlands. He finished his masters in 2019 on developing a low-cost patient monitoring system using ballistography. The focus Bart was part of the pilot study in 2021 with the IMPALA monitoring system at Queen Elizabeth Central Hospital specifically at the Surgical and intensive care unit. The aim for the project should be to crate a system that supports easy detection of deteriorating patients and the clinical workflow.